Parathyroid hormone secretion during citrate anticoagulated hemodialysis in acutely III maintenance hemodialysis patients

Anesthesia and Analgesia

Volumn 99, Issue 4, 2004, Pages 1199-1204

  Apsner, Robert ^a,b   Gruber, Diego ^a   Hörl, Walter H ^a   Sunder Plassmann, Gere ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b Clinic St Therese   (Luxembourg)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; CALCIUM ION; CITRATE TRISODIUM; PARATHYROID HORMONE;

ADULT; AGED; ARTICLE; BLEEDING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HORMONE RELEASE; HUMAN; MALE; PRIORITY JOURNAL;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; BLOOD GAS ANALYSIS; CALCIUM; CITRATES; COAGULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MAGNESIUM; MALE; MIDDLE AGED; PARATHYROID HORMONE; PHOSPHORUS; PROSPECTIVE STUDIES; RENAL DIALYSIS; SODIUM;

EID: 4644231571     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000132780.87036.F5     Document Type: Article

References (24)

1. Flanigan MJ, von Brecht J, Freeman RM, Lim VS. Reducing the hemorrhagic complications of hemodialysis: a controlled comparison of low-dose heparin and citrate anticoagulation. Am J Kidney Dis 1987;9:147-53.
2. Pinnik RV, Wiegmann TB, Diederich DA. Regional citrate anticoagulation for haemodialysis in the patient at high risk for bleeding. N Engl J Med 1983;308:258-61.
3. Apsner R, Druml W. More on anticoagulation for continuous haemofiltration [letter]. N Engl J Med 1998;338:131-2.
4. Palsson R, Niles JL. Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding. Kidney Int 1999;55:1991-7.
5. Kutsogiannis DJ, Mayers I, Chin WD, Gibney RT. Regional citrate anticoagulation in continuous venovenous hemodiafiltration. Am J Kidney Dis 2000;35:802-11.
6. Apsner R, Buchmayer H, Lang T, et al. Simplified citrate anticoagulation for high-flux hemodialysis. Am J Kidney Dis 2001; 38:979-87.
7. Morita Y, Johnson RW, Dorn RE, Hill DS. Regional anticoagulation during hemodialysis using citrate. Am J Med Sci 1961; 242:32-43.
8. Hocken AG, Hurst PL. Citrate regional anticoagulation in haemodialysis. Clin Nephrol 1992;37:36-41.
9. Ludbrook J, Wynn V. Citrate intoxication. Br Med J 1958;30:523-8.
10. Schwarz P, Sorensen HA, Transbol I, McNair P. Induced hypocalcemia controlled by a citrate clamp technique, and the intact parathyroid hormone response obtained. Scand J Clin Lab Invest 1990;50:891-7.
11. Brown EM. Extracellular calcium, regulation of parathyroid cell function, and role of calcium and other ions as extracellular messengers. Physiol Rev 1991;71:371-411.
12. Carlstedt F, Lind L, Rastad J, et al. Parathyroid hormone and ionized calcium levels are related to the severity of illness and survival in critically ill patients. Eur J Clin Invest 1998;28:898-903.
13. Lind L, Carlstedt F, Rastad J, et al. Hypocalcemia and parathyroid hormone secretion in critically ill patients. Crit Care Med 2000;28:93-9.
14. Olinger GN, Hottenrott C, Mulder DG, et al. Acute clinical hypocalcemic myocardial depression during rapid blood transfusion and postoperative hemodialysis: a preventable complication. J Thorac Cardiovasc Surg 1976;72:503-11.
15. Janssen MJFM, Huijgens PC, Bouman AA, et al. Citrate anticoagulation and divalent cations in hemodialysis. Blood Purif 1994;12:308-16.
16. Apsner R, Hörl WH, Sunder-Plassmann G. Dalteparin-induced alopecia in hemodialysis patients: reversal by regional citrate anticoagulation [letter]. Blood 2001;97:2914-5.
17. Unver B, Sunder-Plassmann G, Hörl WH, Apsner R. Long-term citrate anticoagulation for high-flux hemodialysis in a patient with heparin induced thrombocytopenia type II. Acta Med Austriaca 2002;29:146-8.
18. Martin KJ, Gonzalez EA. Strategies to minimize bone disease in renal failure. Am J Kidney Dis 2001;38:1430-6.
19. Smith LM, Cuthbertson B, Harvie J, et al. Increased bone resorption in the critically ill: association with sepsis and increased nitric oxide production. Crit Care Med 2002;30:837-40.
20. Aris RM, Lester GE, Ontjes DA. Bone loss physiology in critically ill patients. Chest 1998;114:954-5.
21. Nierman DM, Mechanick JI. Bone hyperresorption is prevalent in chronically critically ill patients. Chest 1998;114:1122-8.
22. Lind L, Ljunghall S. Critical care hypercalcemia: a hyperparathyroid state. Exp Clin Endocrinol 1992;100:148-51.
23. Massry SG, Arieff AI, Coburn JW, et al. Divalent ion metabolism in patients with acute renal failure: studies on the mechanism of hypocalcemia. Kidney Int 1974;5:437-45.
24. Zaloga GP. Hypocalcemia in critically ill patients. Crit Care Med 1992;20:251-62.